A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract

Forensic Science International

Volumn 179, Issue 2-3, 2008, Pages

  Frison, Giampietro ^a   Favretto, Donata ^a   Zancanaro, Flavio ^a   Fazzin, Giorgio ^b   Ferrara, Santo Davide ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Angel's Hospital of Mestre   (Italy)

Author keywords

Harmaline; Harmine; Intoxication; Peganine; Peganum harmala; Tetrahydroharmine; Carboline alkaloids

Indexed keywords

ALKALOID; BETA CARBOLINE; PEGANUM HARMALA EXTRACT;

ADULT; AGITATION; ARTICLE; ATAXIA; CASE REPORT; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PEGANUM HARMALA; PLANT INTOXICATION; PRIORITY JOURNAL; TREMOR; VISUAL HALLUCINATION; VOMITING;

EID: 47749148060     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2008.05.003     Document Type: Article

References (42)

1. Bellakhdar J. La pharmacopée marocaine traditionnelle. Médecine arabe ancienne et savoirs populaires (1997), Ibis Press, Paris pp. 529-530
2. Sincich F. Bedouin Traditional Medicine in the Syrian Steppe (2002), FAO, Rome pp. 114-115
3. Dymock W., Warden C.J.H., and Hooper D. Pharmacopeia Indica vol. I (1976), Harmard National Foundation of Pakistan, Karachi pp. 252-253
4. Nadikarni K.M. Indian Materia Medica vol. 1 (1976), Popular Pakistan Limited, Bombay pp. 927-929
5. Pieroni A., Muenzc H., Akbulut M., Baser K.H., and Durmuskahya C. Traditional phytotherapy and trans-cultural pharmacy among Turkish migrants living in Cologne, Germany. J. Ethnopharmacol. 102 (2005) 69-88
6. B.A. Donaldson, The Wild Rue: A Study of Muhammadan Magic and Folklore in Iran, Arno Press, New York, 1973 (reprint of 1938 edition published by Luzac, London).
7. Shanon B. Entheogens. J. Conscious. Stud. 9 (2002) 85-94
8. Shanon B. Biblical Entheogens: a Speculative Hypothesis. Time Mind 1 (2008) 51-74
9. Flattery D.S., and Schwartz M. Haoma and harmaline. The Botanical Identity of the Indo-Iranian Sacred Hallucinogen "Soma" and its Legacy in Religion, Language and Middle Eastern Folklore vol. 21 (1989), University of California Publications in Near Eastern Studies pp. 1-121
10. R. Bedrosian, Soma among the Armenians, http://rbedrosian.com/soma.htm, accessed February 2008.
11. Buckholtz N.S., and Boggan W.O. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity. Biochem. Pharmacol. 26 (1977) 1991-1996
12. Kim H., Sablin S.O., and Ramsay R.R. Inhibition of monoamine oxidase A by beta-carboline derivative. Arch. Biochem. Biophys. 337 (1997) 137-142
13. J. Ott, Ayahuasca Analogues. Pangaean Entheogens, Natural Products, Kennewick, 1994.
14. Most A. Peganum Harmala: The Hallucinogenic Herb of the American Southwest (1985), Venom Press, Denton
15. Shulgin A., and Shulgin A. TiHKAL Tryptamines I Have Known and Loved: The Continuation (1997), Transform Press, Berkeley
16. Dobkin de Rios M. Ayahuasca-the healing vine. Int. J. Soc. Psychiatry 17 (1971) 256-269
17. Schultes R.E., and Hofmann A. Plants of the Gods: Origins of Hallucinogenic Use (1979), McGraw-Hill, New York
18. Rivier L., and Lindgren J.E. 'Ayahuasca', the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ. Bot. 26 (1972) 101-129
19. Riba J. Tesi Doctoral (2003), Human Pharmacology of Ayahuasca, Barcelona
20. McKenna D.J., Towers G.H.N., and Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and betacarboline constituents of Ayahuasca. J. Ethnopharmacol. 10 (1984) 195-223
21. Naranjo C. Psychotropic properties of the harmala alkaloids. In: Efron D.H., Holmstedt B., and Kline N.S. (Eds). Ethnopharmacologic Search for Psychoactive Drugs (1967), US Gov Printing Office, Washington, DC 385-391
22. Pennes H.H., and Hoch P.H. Psychotomimetics, clinical and theoretical considerations: harmine, Win-2299 and nalline. Am. J. Psychiatry 113 (1957) 887-892
23. Grella B., Dukat M., Young R., Teitler M., Herrick-Davis K., Gauthier C.B., and Glennon R.A. Investigation of hallucinogenic and related β-carbolines. Drug Alcohol Depend. 50 (1998) 99-107
24. Glennon R.A., Dukat M., Grella B., Hong S., Costantino L., Teitler M., Smith C., Egan C., Davis K., and Mattson M.V. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alcohol Depend. 60 (2000) 121-132
25. Mahmoudian M., Jalilpour H., and Salehian P. Toxicity of Peganum harmala: Review and a Case Report. IJPT (Iranian J. Pharmacol. Ther.) 1 (2002) 1-4
26. Ben Salah N., Amamou M., Jerbi Z., Ben Salah F., and Yacoub M. Un cas de surdosage en Peganum harmala. J. Toxicol. Clin. Exp. 6 (1986) 319-322
27. Brush D.E., Bird S.B., and Boyer E.W. Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J. Toxicol. Clin. Toxicol. 42 (2004) 191-195
28. Balikova M. Collective poisoning with hallucinogenous herbal tea. Forensic Sci. Int. 158 (2002) 50-52
29. Warren R.J. Fatal nicotine intoxication resulting from the ingestion of "Ayahuasca". J. Anal. Toxicol. 28 (2004) 287
30. Sklerov J., Levine B., Moore K.A., King T., and Fowler D.A. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J. Anal. Toxicol. 29 (2005) 838-841
31. El-Bahri L., and Chemli R. Peganum harmala L.: a poisonous plant of North Africa. Vet. Hum. Toxicol. 33 (1991) 276-277
32. Zayed R., and Wink M. Beta-carboline and quinoline alkaloids in root cultures and intact plants of Peganum harmala. Z. Naturforsch. 60 (2005) 451-458
33. Hemmateenejad B., Abbaspour A., Maghami H., Miri R., and Panjehshahin M.R. Partial least squares-based multivariate spectral calibration method for simultaneous determination of beta-carboline derivatives in Peganum harmala seed extracts. Anal. Chim. Acta 575 (2006) 290-299
34. Yritia M., Riba J., Ortuño J., Ramirez A., Castillo A., Alfaro Y., de la Torre R., and Barbanoj M.J. Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca. J. Chromatogr. B 779 (2002) 271-281
35. Callaway J.C., Raymon L.P., Hearn W.L., McKenna D.J., Grob C.S., Brito G.S., and Mash D.C. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with Ayahuasca. J. Anal. Toxicol. 20 (1996) 492-497
36. Callaway J.C., McKenna D.J., Grob C.S., Brito G.S., Raymon L.P., Poland R.E., Andrade E.N., Andrade E.O., and Mash D.C. Pharmacokinetics of Hoasca alkaloids in healthy humans. J. Ethnopharmacol. 65 (1999) 243-256
37. Slotkin T.A., Di Stefano V., and Au W.Y. Blood levels and urinary excretion of harmine and its metabolites in man and rats. J. Pharmacol. Exp. Ther. 173 (1970) 26-30
38. Kartal M., Altun M.L., and Kurucu S. HPLC method for the analysis of harmol, harmalol, harmine and harmaline in the seeds of Peganum harmala L. J. Pharm. Biomed. Anal. 31 (2003) 263-269
39. Iurlo M., Leone G., Schilstrom B., Linner L., Nomikos G., Hertel P., Silvestrini B., and Svensson H. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition. Psychopharmacology 159 (2001) 98-104
40. Tuliaganov N., Sadritdinov F.S., and Suleǐmanova G.A. Pharmacological characteristics of desoxypeganine hydrochloride. Farmakol. Toksikol. 49 (1986) 37-40
41. Bogenschutz M.P. Drug information libraries on the internet. J. Psychoact. Drugs 32 (2000) 249-258
42. Boyer E.W., Shannon M., and Hibberd P.L. Web sites with misinformation about illicit drugs. N. Engl. J. Med. 345 (2001) 469-471